Sort
35,931 grants matching “parkinsons”
Dynamics of synaptic connectivity in a mouse model of alpha-synuclein transmission
$3,459,933Ted M. Dawson · Johns Hopkins University · RF1 · FY2018 · AG
Decoding viral transmission, tropism and inflammation: from single cell to organism
$3,447,539Nihal Altan-Bonnet · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Michigan Alzheimer's Disease Research Center
$3,441,683Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2025 · AG
Michigan Alzheimer's Disease Research Center
$3,437,554Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2024 · AG
Endowment for Disparities Research At Meharry Medical College
$3,437,500Valerie C. Montgomery-Rice · Meharry Medical College · S21 · FY2007 · MD
Endowment for Disparities Research At Meharry Medical College
$3,437,500Valerie C. Montgomery-Rice · Meharry Medical College · S21 · FY2008 · MD
PET Radiopharmaceutical Sciences
$3,432,364Victor W Pike · National Institute Of Mental Health · ZIA · FY2012 · MH
Establishing MicroRNA Biomarkers for Diagnosing Alzheimer's Disease & Predicting Progression
$3,429,850Julie Anne Saugstad · Oregon Health & Science University · RF1 · FY2019 · AG
UCSD Alzheimer's Disease Research Center P50
$3,411,971James B Brewer · University Of California, San Diego · P50 · FY2017 · AG
Gut Liver Brain Biochemical Axis in Alzheimer's Disease
$3,407,970Rima F Kaddurah-Daouk · Duke University · RF1 · FY2018 · AG
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)
$3,402,147Bradley F Boeve · Mayo Clinic Rochester · U01 · FY2015 · AG
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)
$3,395,382Bradley F Boeve · Mayo Clinic Rochester · U01 · FY2017 · AG
Phase 3 trial of inosine for Parkinson's disease CCC
$3,388,840Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2017 · NS
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)
$3,387,908Bradley F Boeve · Mayo Clinic Rochester · U01 · FY2014 · AG
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)
$3,387,606Bradley F Boeve · Mayo Clinic Rochester · U01 · FY2016 · AG
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$3,383,762Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2010 · HG
Biophysical Mechanisms of Cortical MicroStimulation
$3,360,184Sydney S Cash · Massachusetts General Hospital · RF1 · FY2023 · NS
Mitochondrial transport and energy metabolism in synaptic transmission and nerve degeneration and regeneration
$3,355,395Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Alpha Synuclein, cellular dysfunction and Parkinson disease
$3,347,135Mark Cookson · National Institute On Aging · ZIA · FY2020 · AG
Small Molecule Ligands Targeting Pathological Tau Signaling In AD And Related Dementias
$3,336,256Scott Thomas Brady · University Of Illinois At Chicago · RF1 · FY2025 · AG
PET Radiopharmaceutical Sciences
$3,330,051Victor W Pike · National Institute Of Mental Health · ZIA · FY2011 · MH
Stanford Alzheimer's Disease Research Center
$3,298,958Victor W. Henderson · Stanford University · P30 · FY2023 · AG
Inhibition of Abeta42 aggregation by helix stabilizing peptidomimetic biomaterials
$3,297,926Jianfeng Cai · University Of South Florida · RF1 · FY2025 · AG
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$3,290,257Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2025 · HG
Scanning Probe Microscopy for the Intramural Research Community
$3,287,769Emilios K Dimitriadis · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB